SUMMARY Serum and urine steroids were examined in two subjects with trophoblastic disease accompanied by large ovarian theca-lutein cysts and compared with those from 10 patients with trophoblastic disease but without palpable cysts. In the patients without cysts normal values were obtained for serum oestradiol, progesterone, 17a-hydroxyprogesterone and androstenedione, and for urinary total oestrogens, pregnanediol, pregnanetriol, and 17-oxosteroids. Nineteen urinary steroid metabolites, quantified by capillary gas-liquid chromatography, were either within reference limits or marginally raised. In several cases relatively minor increases in serum testosterone and cortisol and urinary free cortisol were observed. In contrast, the subjects with cysts showed pronounced excesses of androgen metabolites, 17a-hydroxypregnanolone, pregnanediol, and pregnanetriol, and both exhibited a similar pattern of unusual additional metabolites.
Steroid excretion in subjects with trophoblastic disease has been little studied but has, in most cases, been reported as within normal limits. Urinary pregnanediol (Table 1) and oestrogens are seldom increased over non-pregnant concentrations,1 2 and trophoblastic tissue is limited in its capacity to synthesise steroids. [3] [4] [5] During routine follow up of subjects with gestational trophoblastic disease two patients had raised concentrations of human chorionic gonadotrophin (hCG) and large theca-lutein cysts of the ovary. In contrast to the other subjects with trophoblastic disease in whom ovarian cysts were not a feature, plasma and urinary steroids in these two patients were increased. Indeed, some steroids were present in very high quantities.
To delineate further the nature and extent of the abnormality urinary steroid metabolites were examined by capillary gas-liquid chromatography and gas Accepted for publication 9 January 1986 chromatography-mass spectrometry. Ten further subjects with gestational trophoblastic disease but without palpable ovarian cysts were also studied to determine whether the subjects with cysts would show a discrete disorder or one extreme of a continuum. This also permitted an assessment of whether these unusual metabolites originated in the trophoblastic tissue or the ovary.
Case histories CASE I
A 23 year old primigravida had an evacuation of a hydatidiform mole at about 12 weeks' gestation. One month later she was admitted for chemotherapy in view of raised urinary hCG concentrations (9830 IU/24 hours), persistent irregular vaginal blood loss, dyspnoea, chest pain, and colicky abdominal pain. Clinically, she had a bulky uterus with a large separate mass arising from the pelvis. Ultrasonography showed this to be an ovarian cyst 22 cm 177#-Hydroxy-4-androsten-3-one 3a-Hydroxy-5a-androstan-1 7-one 3a, 1If-Dihydroxy-5a-androstan-17-one 3a-Hydroxy-5fl-androstan-17-one 3a, 1 1fI-Dihydroxy-5fi-androstan-1 7-one 3a-Hydroxy-5f-androstane-1 1, 17-dione 4-Androstene-3, 17-dione 5-Androstene-3f, 16a, 17/i-triol 3fi-Hydroxy-5-androsten-1 7-one 3f, 16a-Dihydroxy-5-androsten-I 7-one 3#-Hydroxy-5-pregnen-20-one 3fi, 17a-Dihydroxy-5-pregnen-20-one 3fi, 16a-Dihydroxy-5-pregnen-20-one 4.Pregnene-3, 20-dione 16a-Hydroxy-4-pregnene-3, 20-dione 5f-Pregnane-3a, 20a-diol 3a-Hydroxy-5#-pregnan-20-one 17a-Hydroxy-4-pregnene-3, 20-dione 3a, 17a-Dihydroxy-5p-pregnan-20-one 5f-Pregnane-3a, 17a, 20a-triol 17a, 17a, 11#, 17a, 21-Trihydroxy-4-pregnene-3, 20-dione 3a, II#, 17a, 21-Tetrahydroxy-5p-pregnan-20-one 3a, 11#, 17a, 21-Tetrahydroxy-5a-pregnan-20-one 3a, 17a, 21-Trihydroxy-5fi-pregnane-1 1, 20-dione 3a, 21-Dihydroxy-5f-pregnane-1 1, 20-dione 3a, IlI#, 3a, II#, 21-Trihydroxy-5a-pregnan-20-one 3a, 17a, 20a, 21-Tetrahydroxy-5f-pregnan-1 I-one 3a, 17a, 20(, 21-Tetrahydroxy-5p-pregnan-l1-one S5-Pregnane-3a, 11I3, 17a, 20a, 21-pentol 5-Pregnane-3a, 11,B, 17a, 20ft, 21 A gravida 2 para 1 patient had an evacuation of a 13 week gestation hydatidiform mole at the age of 25. Six weeks later she presented with a raised serum ,BhCG concentration of 21 030 IU/I, urinary hCG of 16480 IU/24 hours, gross abdominal distension (Fig. 1) , and amenorrhoea. Examination showed a cystic swelling arising from the pelvis, and ultrasonography showed this to be consistent with a large ovarian cyst (Fig. 2) . Chest x-ray showed multiple pulmonary metastases. She received five courses of methotrexate and five courses of second line treatment after which a chest radiograph, ultrasonography, and hCG excretion all yielded normal results. *On this profile 17a-hydroxypregnanolone (20) and 110-hydroxyandrosterone (5) could not be separated (gas-chromatography-mass spectrometry showed that principal contributor to peak was 17a-hydroxypregnanolone).°P eak overlaid with 3a-hydroxy-5#-pregnane-20-one.
-Steroid not found. Conversion to traditional units: g = mol x molecular weight. A Table 2 lists the principal steroid metabolites found in urine from normal adults on gas chromatographic analysis, and Table 3 lists those additional compounds found in significant amounts only in the subjects with cysts. Table 4 compares plasma steroid hormones and urinary metabolites between the groups. Fig. 3 shows a gas chromatogram of urinary steroids in case 2. That obtained for case 1 was qualitatively very similar. Excretion of the following steroids was raised: pregnanetriol, pregnanediol, and the Cl9 androgens, androsterone, aetiocholanolone and DHA, together with their hydroxylated products. The C21 corticoids are increased in case 2 and within normal limits in case 1. In addition, oestrogen excretion was grossly increased (Table 4) . Tables I and 2 Pathways leading to the formation of normal and additional steroids shown by dashed and dotted lines, respectively. Numbers in parentheses refer to steroids listed in Table 2 .
The predominance of 17a-hydroxypregnanolone and pregnanetriol is also a feature of steroid excretion in 21-hydroxylase deficiency. There were, however, few similarities between the other components of the profiles. There were several 16-hydroxylated metabolites present in the subjects, but these are almost absent in 21-hydroxylase deficiency (Fig. 4) . Recently, the presence of several 15-hyroxylated metabolites has been shown in 21-hydroxylase deficiency (Taylor NF, unpublished observations). There was no trace of these in either of the patients studied. Lesser quantities of pregnenolone and minimal quantities of 17a-hydroxyprogesterone and 17a-hydroxypregnenolone were also detected. Addition of calf serum to the incubates resulted in only minor increments in synthesis of any of these steroids but, in contrast, facilitated a many fold increase in oestradiol production, probably by providing androgen precursors. As expected, addition of androgens stimulated oestradiol synthesis. The authors concluded that trophoblastic tissue lacked 17-20 desmolase and 17a-hydroxylase, but that 3f-hydroxysteroid dehydrogenase, A 4 A 5 isomerase, 17#-hydroxysteroid dehydrogenase, and aromatase were all active. Similar results were obtained by Maeyama etal5 in homogenates of choriocarcinoma tissue in that they too were unable to show sidechain cleavage.
Conflicting results, however, were reported by van Leusden,13 who obtained evidence for side chain cleavage when incubating tritiated pregnenolone with chorionepithelioma tissue and showed the formation of androsterone, testosterone, oestrone, and oestradiol. The reason for the discrepancies in this work and that of the Maeyama and Bahn groups is not clear but may be due to the nature of the tissue studied by the different authors. Van Leusden investigated uterine chorionepithelioma, a primary focus, whereas Maeyama's group used cerebral metastatic tissue, and Bahn etal cultured chorionepithelioma cells.
In most cases of trophoplastic disease plasma oestrogen and progesterone concentrations have been found to be low or within normal limits for non pregnant subjects,2 and urinary pregnanediol and oestrogen excretions have also been found to be low compared with those found in normal pregnancy.1 632 Bevan, Savvas, Jenkins, Baker, Pennington, Taylor group.bmj.com on August 28, 2017 -Published by http://jcp.bmj.com/ Downloaded from Steroids in gestational trophoblastic disease complicated by ovarian theca-lutein cysts On the basis of plasma progesterone assays Teoh etal"4 considered that choriocarcinoma tissue had only a limited capacity for steroidogenesis. Dawood,' however, asserted that plasma progesterone concentrations correlated with the degree of differentiation of the trophoblastic tissue-concentrations were low in avillous carcinoma but higher in cases of invasive mole and villous carcinoma. He also found a correlation between hCG concentrations and progesterone in choriocarcinoma and believed that the ovaries were the principal source of the progesterone under stimulation from hCG.
Sadoff et al" reported that in a male patient with metastatic choriocarcinoma, pretreatment plasma concentrations of cortisol, testosterone, and oestradiol were all grossly increased. High hCG values in the cerebrospinal fluid showed that the patient had developed cerebral metastases. Cerebrospinal fluid steroid concentrations, however, were low, suggesting that it was unlikely that the metastatic tissue was the source of the raised plasma steroids, and, more probably, that they had originated from the testis or adrenal gland, or both.
STEROIDOGENESIS BY THECA-LUTEIN CYSTS
Ovarian follicles are known to possess the capacity for side chain cleavage of C21 steroids and also 17a-hydroxylase and 16a-hydroxylase activities: they lack II,B-and 21-hydroxylase activities. 16 Steroid values in fluid from pre-ovulatory follicles and in thecalutein cysts have been reported as being very similar.17 The principal progestins present, such as progesterone, 1 7cx-hydroxyprogesterone, 1 6a-hydroxyprogesterone, and 20-dihydroprogesterone, are potential precursors of the additional compounds identified in cases 1 and 2 (Table 3 and Fig. 4) . Likewise, the principal androgens reported, DHA sulphate and androsterone sulphate, might account for the high concentrations of the urinary androgen metabolites, androsterone, aetiocholanolone, and 16a-hydroxy DHA. Oestradiol concentrations were relatively lower in cyst fluids than in normal follicles, and interestingly, in our patients with ovarian cysts oestrogen concentrations were proportionately less raised than were progesterone and 1 7a-hydroxyprogesterone and their metabolites.
There have been comparatively few other assessments reported on the contribution of theca-lutein cysts to steroidogenesis, and most published reports have been concerned with steroid production in hydatidiform moles. Stitch et all8 reported a case of molar pregnancy associated with increased urinary pregnanetriol excretion. At the time of removal of the mole by abdominal hysterectomy the ovaries were seen to contain massive theca-lutein cysts, which were believed to have enlarged further immediately after the operation: concomitantly, urinary pregnanetriol output became even higher than before and only returned to normal as the cysts regressed. The authors considered the cystic ovaries to be the most likely source of the pregnanetriol precursors.
Reporting on a similar case of hydatidiform mole with theca-lutein cysts and increased urinary pregnanetriol excretion, Coutts et al'9 concluded that, although molar tissue was active in steroid metabolism, the excessive pregnanetriol originated from the polycystic ovaries. In support of these conclusions evidence was presented that whereas molar tissue contained pregnenolone, 17a-hydroxypregnenolone, pregnanediol, pregnanetriol, and androstenedione, I 7ax-hydroxyprogesterone was undetectable and progesterone present only in trace amounts. On the other hand, theca-lutein cyst fluid was found to contain all these steroids, progesterone and 1 7a-hydroxyprogesterone being present in considerable quantities.
Dawood, Ratnam, and Teoh20 and Dawood2' investigated molar pregnancies with and without theca-lutein cysts. They showed that in both "intact" moles that is, before loss of vesicular tissue and aborted moles the presence of ovarian cysts was accompanied by higher plasma oestradiol and progesterone concentrations. They suggested that molar tissue was an active steroidogenic tissue but that there was additional steroid synthesis from the ovary when theca-lutein cysts were present.
The only report concerning the effect of cystic ovaries is that of Samaan et a122 who reported raised plasma testosterone concentrations in women with trophoblastic disease and showed that the highest testosterone values were seen in those patients in whom the ovaries were grossly enlarged. Oophorectomy and chemotherapy were effective in reducing both hCG and testosterone values. Cyst fluid was obtained at laparotomy from the ovaries of a patient with metastatic trophoblastic disease and enlarged ovaries, and it was shown that the content of testosterone was much higher than in the circulation. It was suggested that the ovarian cysts might be a principal site of testosterone formation but, because oophorectomy was not required in this patient, they were unable to rule out other possible sites of testosterone production.
In the patients with trophoblastic disease complicated by the presence of ovarian theca-lutein cysts reported here the principal steroids present in excess in serum and urine were similar to those shown by Vanleuchene et al'7 to be the normal constituents of lutein cyst fluid. They also comprised the steroids shown by Abraham23 to be those that peak at mid cycle and are not diminished by dexamethasone suppression, indicating an ovarian origin.
The report of Teoh etal'4 that choriocarcinoma tissue has only a limited capacity for steroidogenesis, and the suggestion by Sadoff etal1 that metastases were unlikely to be the source of raised plasma steroids in metastatic choriocarcinoma support the concept that the most probable source of the abnormal and grossly raised steroids in our patients were the large ovarian cysts. The available evidence suggests that, similarly to ovarian tissue, theca-lutein cysts possess the enzymes required for progestin, androgen and oestrogen synthesis. We suggest that the secretions result from the enormous proliferation of thecalutein cells under the influence of excessive circulating hCG.
We also suggest that the additional steroids in the profiles of the cystic subjects arose from saturation of the normal metabolic excretion pathways, such that sufficient substrates were available for the activation of other pathways, present in all subjects but normally only minimally used, thus resulting in the observed bizarre excretion patterns. Fig 4 shows the possible metabolic pathways. These suggestions, however, can only be advanced with caution because of the incomplete characterisation of several of the steroids in the profile. In addition, a possible contribution from the trophoblastic tissue to steroid synthesis cannot be ignored.
To confirm the source of the "abnormal" steroids of the type described, which, at least superficially, mimic 21-hydroxylase deficiency, we suggest that simultaneous measurement of the steroids in both cyst fluid and the general circulation should be carried out in cases of trophoblastic disease with ovarian enlargement. It may also be of interest to measure the steroid content of the same two tissues in cases of hyperstimulation following follicle stimulating hormone treatment for infertility. The absence of trophoblastic tissue in infertility would certainly lead to a more accurate assessment of the likely source.
